Ontology highlight
ABSTRACT: Background
The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years.Objective
To inform HIV treatment decisions about the optimal CD4 threshold at which to initiate ART in South Africa while awaiting the results of these trials.Design
Cost-effectiveness analysis by using a computer simulation model of HIV disease.Data sources
Published data from randomized trials and observational cohorts in South Africa.Target population
HIV-infected patients in South Africa.Time horizon
5-year and lifetime.Perspective
Modified societal.Intervention
No treatment, ART initiated at a CD4 count less than 0.250 x 10(9) cells/L, and ART initiated at a CD4
SUBMITTER: Walensky RP
PROVIDER: S-EPMC3092478 | biostudies-literature | 2009 Aug
REPOSITORIES: biostudies-literature